BEST4 clinical trial: Principal Investigator

Activity: Other activity typesOther

Description

Randomised controlled trial of targeted screening using the Cytosponge-TFF3 test to determine whether it would have a clinically important impact on oesophageal cancer mortality
Period07 Oct 202221 Feb 2025
Held atUniversity of Cambridge, United Kingdom
Degree of RecognitionNational